Earnings Per Share

6 Months Ended

Jun. 30, 2019

Basic earnings per share (“basic EPS”) is computed by dividing net income by the weighted average number of common shares outstanding for the reporting period. Diluted earnings per share (“diluted EPS”) gives effect to all dilutive potential shares outstanding resulting from employee stock options, restricted stock units, performance share units and stock appreciation rights ("SARs") during the period.

The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2019 and 2018:



	Three Months Ended June 30,				Six Months Ended June 30,
	2019		2018		2019		2018
Net income	$	5,695	$	8,719	$	6,716	$	19,376

Basic – weighted average shares outstanding	28,276		28,075		28,228		28,059

Effect of dilutive potential securities	1,061		771		969		680

Diluted – weighted average shares outstanding	29,337		28,846		29,197		28,739

Net income (per share)
Basic	$	0.20	$	0.31	$	0.24	$	0.69
Diluted	0.19		0.30		0.23		0.67

The shares used in the calculation of diluted EPS exclude options and SARs to purchase shares where the exercise price was greater than the average market price of common shares for the period and the effect of the inclusion would be anti-dilutive. Such shares aggregated approximately 0.8 million and 0.6 million for the three and six months ended June 30, 2019, respectively, and 0.8 million and 0.5 million for the three and six months ended June 30, 2018, respectively. As more fully described in Note 17, our 2.625% convertible notes due in 2024 (the “Notes”) are convertible under certain circumstances, as defined in the indenture, into a combination of cash and CONMED common stock. Potential dilution upon conversion of the Notes occurs when the market price per share of our common stock, is greater than the conversion price of the Notes of $88.80. We intend to settle in cash the principal outstanding and use the treasury stock method when calculating their potential dilutive effect, if any. We have entered into convertible note hedge transactions to increase the effective conversion price of the Notes to $114.92. However, our convertible note hedges are not included when calculating potential dilutive shares since their effect is always anti-dilutive. As of June 30, 2019, our share price has not exceeded the conversion price of the Notes; therefore, under the net share settlement method, there were no potential shares issuable under the Notes to be used in the calculation of diluted EPS.